Back
Nutanix, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Sell
31
NTNX
Nutanix, Inc.
Last Price:
$47.58
Seasonality Move:
-3.58%
Buy
67
GPCR
Structure Therapeutics, Inc.
Last Price:
$68.25
Seasonality Move:
-31.39%
Sell
31
Nutanix, Inc. (NTNX)
is a Sell
Is Nutanix, Inc. a Buy, Sell or Hold?
-
The current Nutanix, Inc. [NTNX] share price is $47.39. The Score for NTNX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
NTNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NTNX Stock Price Chart
What is Nutanix, Inc.'s stock price today?
-
The Nutanix, Inc. share price today is $47.39Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTNX is experiencing selling pressure, which indicates risk of future bearish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
NTNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.9 | Sell |
| Relative Strength Index (14 RSI): | 20.07 | Sell |
| Chaikin Money Flow: | -3099126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.35 - 68.99) | Sell |
| Bollinger Bands (100): | (61.18 - 76.9) | Sell |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.48 | Buy |
| Relative Strength Index (14 RSI): | 86.01 | Buy |
| Chaikin Money Flow: | 124529 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.63 - 42.89) | Buy |
| Bollinger Bands (100): | (18.11 - 33.75) | Buy |
NTNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.4 | Sell |
| 20-day SMA: | 57.13 | Sell |
| 50-day SMA: | 65.13 | Sell |
| 200-day SMA: | 70.64 | Sell |
| 8-day EMA: | 49.13 | Sell |
| 20-day EMA: | 55.05 | Sell |
| 50-day EMA: | 62.39 | Sell |
| 200-day EMA: | 67.96 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.22 | Buy |
| 20-day SMA: | 36.44 | Buy |
| 50-day SMA: | 32.1 | Buy |
| 200-day SMA: | 23.71 | Buy |
| 8-day EMA: | 41.78 | Buy |
| 20-day EMA: | 37.11 | Buy |
| 50-day EMA: | 32.59 | Buy |
| 200-day EMA: | 27.3 | Buy |
Nutanix, Inc. Earnings Growth & NTNX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.09 per share, an increase this year of $0.52 per share, and an increase next year of $0.06 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.
Nutanix, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||